Repare Therapeutics Shares Are Trading Higher After the Company Announced It Will Present Its Phase 1/2 Cancer Trial Data at the European Society of Medical Oncology Congress (ESMO).
Repare Therapeutics Shares Are Trading Higher After the Company Announced It Will Present Its Phase 1/2 Cancer Trial Data at the European Society of Medical Oncology Congress (ESMO).
Repare Therapeutics股价上涨,因该公司宣布将在欧洲医学肿瘤学会议(ESMO)上公布其Phase 1/2癌症试验数据。
Repare Therapeutics Shares Are Trading Higher After the Company Announced It Will Present Its Phase 1/2 Cancer Trial Data at the European Society of Medical Oncology Congress (ESMO).
Repare Therapeutics股价上涨,因该公司宣布将在欧洲医学肿瘤学会议(ESMO)上公布其Phase 1/2癌症试验数据。